Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 1

Conditions

Radiation Injuries 4Medulloblastoma 3Choroid Plexus Neoplasms 3Central Nervous System Neoplasms 3Brain Neoplasms 3Astrocytoma 3Pinealoma 2Oligodendroglioma 2Neuroectodermal Tumors, Primitive 2Meningioma 2Gliosarcoma 2Glioma, Subependymal 2Glioma 2Glioblastoma 2Fatigue 2Ependymoma 2Depression 2Craniopharyngioma 2Cognitive Dysfunction 2Breast Neoplasms 2Uterine Cervical Neoplasms 1Urinary Retention 1Spinal Cord Neoplasms 1Small Cell Lung Carcinoma 1Sleep Wake Disorders 1Optic Nerve Glioma 1Neurotoxicity Syndromes 1Neoplasm Metastasis 1Memory Disorders 1Lung Neoplasms 1

Interventions

Music Therapy 15Cognitive Behavioral Therapy 13Therapeutics 12Surveys and Questionnaires 12Psychiatric Rehabilitation 9Methods 9Standard of Care 8Psilocybin 7Educational Status 7Mindfulness 6Hypnosis 6Early Intervention, Educational 6Mindfulness-Based Stress Reduction 5Mindfulness-Based Cognitive Therapy 5Massage 5Control Groups 5Art Therapy 5Aromatherapy 5Saline Solution 4Ketamine 4Interviews as Topic 4Imagery, Psychotherapy 4Esketamine 4Behavior Therapy 4Autogenic Training 4Acupuncture Therapy 4Yoga 3Weights and Measures 3Touch 3Therapeutic Touch 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Anxiety Disorders × Donepezil × Clear all
NCT01466270 2021-10-20

Study of Donepezil in Female Breast Cancer Survivors With Cognitive Dysfunction

Wake Forest University Health Sciences

Phase 2 Completed
62 enrolled 12 charts
Breast

Anxiety Disorders, Breast Neoplasms, Cognition Disorders, Depression, Fatigue, Sleep Wake Disorders

Data powered by HemOnc (CC BY 4.0) Colophon âš¡